Streamex Corp. (STEX): Nasdaq/NYSE listing notice — BioSig receives Nasdaq MVLS deficiency notice; faces potential delisting

Streamex Corp.

MVLS fell below $35M for 30 consecutive business days ending Dec 18, 2023.
Company has 180 calendar days (until June 17, 2024) to regain MVLS compliance.
Also has an outstanding bid price deficiency with compliance period ending Mar 4, 2024.
If MVLS compliance not regained, company may be ineligible for additional bid price cure period.
Letter has no immediate impact on listing; stock continues trading on Nasdaq.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Streamex Corp. received a nasdaq deficiency notice notice regarding market value (rules 5810(c)(3)(C), 5550(b)(3)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5810(c)(3)(C), 5550(b)(3)

Exact text from the filing

n which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(C). In order to regain compliance with Nasdaq’s minimum MVLS requirement, the Company’s MVLS must close at $35,000,000 or more for

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001493152-23-045925

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.